Head-To-Head Review: InterCure (NASDAQ:INCR) & Cresco Labs (OTCMKTS:CRLBF)

InterCure (NASDAQ:INCR) and Cresco Labs (OTCMKTS:CRLBF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Volatility & Risk

InterCure has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500. Comparatively, Cresco Labs has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500.

Earnings and Valuation

This table compares InterCure and Cresco Labs”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$64.55 million	N/A	-$18.32 million	$0.13	10.15
Cresco Labs	$724.34 million	0.41	-$74.44 million	($0.15)	-5.57

InterCure has higher earnings, but lower revenue than Cresco Labs. Cresco Labs is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings for InterCure and Cresco Labs, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1	0	0	0	1.00
Cresco Labs	0	2	1	0	2.33

Institutional & Insider Ownership

8.3% of InterCure shares are owned by institutional investors. Comparatively, 0.1% of Cresco Labs shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares InterCure and Cresco Labs’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
Cresco Labs	-7.79%	-14.25%	-3.90%

Summary

InterCure beats Cresco Labs on 7 of the 11 factors compared between the two stocks.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

About Cresco Labs

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.